141 related articles for article (PubMed ID: 18951945)
1. Naringin-induced p21WAF1-mediated G(1)-phase cell cycle arrest via activation of the Ras/Raf/ERK signaling pathway in vascular smooth muscle cells.
Lee EJ; Moon GS; Choi WS; Kim WJ; Moon SK
Food Chem Toxicol; 2008 Dec; 46(12):3800-7. PubMed ID: 18951945
[TBL] [Abstract][Full Text] [Related]
2. Requirement for Ras/Raf/ERK pathway in naringin-induced G1-cell-cycle arrest via p21WAF1 expression.
Kim DI; Lee SJ; Lee SB; Park K; Kim WJ; Moon SK
Carcinogenesis; 2008 Sep; 29(9):1701-9. PubMed ID: 18296682
[TBL] [Abstract][Full Text] [Related]
3. Magnolol elicits activation of the extracellular signal-regulated kinase pathway by inducing p27KIP1-mediated G2/M-phase cell cycle arrest in human urinary bladder cancer 5637 cells.
Lee SJ; Cho YH; Park K; Kim EJ; Jung KH; Park SS; Kim WJ; Moon SK
Biochem Pharmacol; 2008 Jun; 75(12):2289-300. PubMed ID: 18468578
[TBL] [Abstract][Full Text] [Related]
4. Honokiol causes the p21WAF1-mediated G(1)-phase arrest of the cell cycle through inducing p38 mitogen activated protein kinase in vascular smooth muscle cells.
Lee B; Kim CH; Moon SK
FEBS Lett; 2006 Oct; 580(22):5177-84. PubMed ID: 16962592
[TBL] [Abstract][Full Text] [Related]
5. Zedoarondiol Inhibits Platelet-Derived Growth Factor-Induced Vascular Smooth Muscle Cells Proliferation via Regulating AMP-Activated Protein Kinase Signaling Pathway.
Mao H; Tao T; Song D; Liu M; Wang X; Liu X; Shi D
Cell Physiol Biochem; 2016; 40(6):1506-1520. PubMed ID: 27997894
[TBL] [Abstract][Full Text] [Related]
6. Ras/ERK1 pathway regulation of p27KIP1-mediated G1-phase cell-cycle arrest in cordycepin-induced inhibition of the proliferation of vascular smooth muscle cells.
Jung SM; Park SS; Kim WJ; Moon SK
Eur J Pharmacol; 2012 Apr; 681(1-3):15-22. PubMed ID: 22366198
[TBL] [Abstract][Full Text] [Related]
7. p38 MAPK activation is required for esculetin-induced inhibition of vascular smooth muscle cells proliferation.
Yun ES; Park SS; Shin HC; Choi YH; Kim WJ; Moon SK
Toxicol In Vitro; 2011 Oct; 25(7):1335-42. PubMed ID: 21600278
[TBL] [Abstract][Full Text] [Related]
8. Ras/ERK signaling pathway mediates activation of the p21WAF1 gene promoter in vascular smooth muscle cells by platelet-derived growth factor.
Lee B; Moon SK
Arch Biochem Biophys; 2005 Nov; 443(1-2):113-9. PubMed ID: 16248979
[TBL] [Abstract][Full Text] [Related]
9. PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: involvement of p38 mitogen activated protein kinase.
Moon SK; Jung SY; Choi YH; Lee YC; Patterson C; Kim CH
J Cell Physiol; 2004 Feb; 198(2):310-23. PubMed ID: 14603533
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
11. Eupatilin, a pharmacologically active flavone derived from Artemisia plants, induces cell cycle arrest in ras-transformed human mammary epithelial cells.
Kim DH; Na HK; Oh TY; Kim WB; Surh YJ
Biochem Pharmacol; 2004 Sep; 68(6):1081-7. PubMed ID: 15313404
[TBL] [Abstract][Full Text] [Related]
12. Transcription factor Sp1 mediates p38MAPK-dependent activation of the p21WAF1 gene promoter in vascular smooth muscle cells by pyrrolidine dithiocarbamate.
Moon SK; Jung SY; Kim CH
Biochem Biophys Res Commun; 2004 Apr; 316(3):605-11. PubMed ID: 15033443
[TBL] [Abstract][Full Text] [Related]
13. Sanguinarine-induced G1-phase arrest of the cell cycle results from increased p27KIP1 expression mediated via activation of the Ras/ERK signaling pathway in vascular smooth muscle cells.
Lee B; Lee SJ; Park SS; Kim SK; Kim SR; Jung JH; Kim WJ; Moon SK
Arch Biochem Biophys; 2008 Mar; 471(2):224-31. PubMed ID: 18237541
[TBL] [Abstract][Full Text] [Related]
14. Interferon regulatory factor-1 together with reactive oxygen species promotes the acceleration of cell cycle progression by up-regulating the cyclin E and CDK2 genes during high glucose-induced proliferation of vascular smooth muscle cells.
Zhang X; Liu L; Chen C; Chi YL; Yang XQ; Xu Y; Li XT; Guo SL; Xiong SH; Shen MR; Sun Y; Zhang CS; Hu KM
Cardiovasc Diabetol; 2013 Oct; 12():147. PubMed ID: 24119616
[TBL] [Abstract][Full Text] [Related]
15. Protein kinase C alpha trigger Ras and Raf-independent MEK/ERK activation for TPA-induced growth inhibition of human hepatoma cell HepG2.
Wen-Sheng W
Cancer Lett; 2006 Jul; 239(1):27-35. PubMed ID: 16169661
[TBL] [Abstract][Full Text] [Related]
16. Apamin inhibits PDGF-BB-induced vascular smooth muscle cell proliferation and migration through suppressions of activated Akt and Erk signaling pathway.
Kim JY; Kim KH; Lee WR; An HJ; Lee SJ; Han SM; Lee KG; Park YY; Kim KS; Lee YS; Park KK
Vascul Pharmacol; 2015 Jul; 70():8-14. PubMed ID: 25737404
[TBL] [Abstract][Full Text] [Related]
17. The effects of BuYang HuanWu Decoction and its effective components on proliferation-related factors and ERK1/2 signal transduction pathway in cultured vascular smooth muscle cells.
Chen G; Wu L; Deng CQ
J Ethnopharmacol; 2011 Apr; 135(1):7-14. PubMed ID: 21385603
[TBL] [Abstract][Full Text] [Related]
18. Asperolide A, a marine-derived tetranorditerpenoid, induces G2/M arrest in human NCI-H460 lung carcinoma cells, is mediated by p53-p21 stabilization and modulated by Ras/Raf/MEK/ERK signaling pathway.
Lv C; Sun W; Sun H; Wei S; Chen R; Wang B; Huang C
Mar Drugs; 2013 Jan; 11(2):316-31. PubMed ID: 23434831
[TBL] [Abstract][Full Text] [Related]
19. Blockade of the Ras-extracellular signal-regulated kinase 1/2 pathway is involved in smooth muscle 22 alpha-mediated suppression of vascular smooth muscle cell proliferation and neointima hyperplasia.
Dong LH; Wen JK; Liu G; McNutt MA; Miao SB; Gao R; Zheng B; Zhang H; Han M
Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):683-91. PubMed ID: 20139360
[TBL] [Abstract][Full Text] [Related]
20. Sorafenib inhibits non-small cell lung cancer cell growth by targeting B-RAF in KRAS wild-type cells and C-RAF in KRAS mutant cells.
Takezawa K; Okamoto I; Yonesaka K; Hatashita E; Yamada Y; Fukuoka M; Nakagawa K
Cancer Res; 2009 Aug; 69(16):6515-21. PubMed ID: 19638574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
